CVS Health PE Ratio 2010-2024 | CVS
Current and historical p/e ratio for CVS Health (CVS) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CVS Health PE ratio as of May 15, 2025 is 9.51.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CVS Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-16 | 62.53 | 17.08 | |
| 2024-12-31 | 43.87 | $3.66 | 11.99 |
| 2024-09-30 | 60.78 | $3.94 | 15.43 |
| 2024-06-30 | 56.45 | $5.62 | 10.04 |
| 2024-03-31 | 75.51 | $5.69 | 13.27 |
| 2023-12-31 | 74.07 | $6.46 | 11.47 |
| 2023-09-30 | 64.94 | $6.63 | 9.80 |
| 2023-06-30 | 63.78 | $2.28 | 27.97 |
| 2023-03-31 | 68.00 | $3.03 | 22.44 |
| 2022-12-31 | 84.69 | $3.12 | 27.14 |
| 2022-09-30 | 86.15 | $2.35 | 36.66 |
| 2022-06-30 | 83.22 | $6.15 | 13.53 |
| 2022-03-31 | 90.43 | $6.02 | 15.02 |
| 2021-12-31 | 91.68 | $5.96 | 15.38 |
| 2021-09-30 | 74.98 | $5.72 | 13.11 |
| 2021-06-30 | 73.28 | $5.45 | 13.45 |
| 2021-03-31 | 65.64 | $5.61 | 11.70 |
| 2020-12-31 | 59.20 | $5.46 | 10.84 |
| 2020-09-30 | 50.19 | $6.05 | 8.30 |
| 2020-06-30 | 55.41 | $6.29 | 8.81 |
| 2020-03-31 | 50.18 | $5.52 | 9.09 |
| 2019-12-31 | 62.41 | $5.08 | 12.28 |
| 2019-09-30 | 52.58 | $3.38 | 15.56 |
| 2019-06-30 | 45.03 | $3.57 | 12.61 |
| 2019-03-31 | 44.14 | $-0.44 | 0.00 |
| 2018-12-31 | 53.22 | $-0.55 | 0.00 |
| 2018-09-30 | 63.50 | $3.04 | 20.89 |
| 2018-06-30 | 51.52 | $2.94 | 17.52 |
| 2018-03-31 | 49.43 | $6.53 | 7.57 |
| 2017-12-31 | 57.25 | $6.47 | 8.85 |
| 2017-09-30 | 63.79 | $4.84 | 13.18 |
| 2017-06-30 | 62.71 | $5.01 | 12.52 |
| 2017-03-31 | 60.79 | $4.80 | 12.66 |
| 2016-12-31 | 60.74 | $4.92 | 12.35 |
| 2016-09-30 | 68.16 | $4.67 | 14.60 |
| 2016-06-30 | 73.01 | $4.35 | 16.78 |
| 2016-03-31 | 78.78 | $4.61 | 17.09 |
| 2015-12-31 | 73.92 | $4.64 | 15.93 |
| 2015-09-30 | 72.70 | $4.44 | 16.37 |
| 2015-06-30 | 78.78 | $4.14 | 19.03 |
| 2015-03-31 | 77.26 | $4.08 | 18.94 |
| 2014-12-31 | 71.84 | $3.96 | 18.14 |
| 2014-09-30 | 59.17 | $3.87 | 15.29 |
| 2014-06-30 | 55.83 | $4.08 | 13.68 |
| 2014-03-31 | 55.25 | $3.93 | 14.06 |
| 2013-12-31 | 52.60 | $3.75 | 14.03 |
| 2013-09-30 | 41.55 | $3.60 | 11.54 |
| 2013-06-30 | 41.71 | $3.37 | 12.38 |
| 2013-03-31 | 39.96 | $3.21 | 12.45 |
| 2012-12-31 | 34.98 | $3.03 | 11.54 |
| 2012-09-30 | 34.91 | $2.94 | 11.87 |
| 2012-06-30 | 33.58 | $2.80 | 11.99 |
| 2012-03-31 | 32.07 | $2.65 | 12.10 |
| 2011-12-31 | 29.08 | $2.58 | 11.27 |
| 2011-09-30 | 23.87 | $2.52 | 9.47 |
| 2011-06-30 | 26.62 | $2.46 | 10.82 |
| 2011-03-31 | 24.22 | $2.46 | 9.85 |
| 2010-12-31 | 24.45 | $2.49 | 9.82 |
| 2010-09-30 | 22.07 | $2.48 | 8.90 |
| 2010-06-30 | 20.50 | $2.60 | 7.88 |
| 2010-03-31 | 25.50 | $2.60 | 9.81 |
| 2009-12-31 | 22.41 | $2.55 | 8.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $76.496B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.657B | 25.63 |
| Elevance Health (ELV) | United States | $88.114B | 11.37 |
| Cencora (COR) | United States | $55.428B | 19.28 |
| DiDi Global (DIDIY) | China | $22.215B | 33.71 |
| Natera (NTRA) | United States | $20.400B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.620B | 13.36 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.158B | 0.00 |
| CochLear (CHEOY) | Australia | $11.298B | 0.00 |
| Doximity (DOCS) | United States | $10.912B | 50.83 |
| Revvity (RVTY) | United States | $10.655B | 18.34 |
| ICON (ICLR) | Ireland | $10.552B | 9.81 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Avantor (AVTR) | United States | $8.750B | 12.71 |
| Medpace Holdings (MEDP) | United States | $8.519B | 22.63 |
| HealthEquity (HQY) | United States | $8.446B | 41.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.822B | 13.37 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.185B | 38.74 |
| Bausch + Lomb (BLCO) | Canada | $4.171B | 24.58 |
| Sotera Health (SHC) | United States | $3.616B | 20.55 |
| Surgery Partners (SGRY) | United States | $3.029B | 39.39 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Concentras Parent (CON) | United States | $2.925B | 16.90 |
| Organon (OGN) | United States | $2.280B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.179B | 9.29 |
| Progyny (PGNY) | United States | $1.882B | 41.42 |
| Premier (PINC) | United States | $1.877B | 14.24 |
| GeneDx Holdings (WGS) | United States | $1.815B | 69.90 |
| PACS (PACS) | United States | $1.625B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Pediatrix Medical (MD) | United States | $1.278B | 9.73 |
| Teladoc Health (TDOC) | United States | $1.272B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
| Agilon Health (AGL) | United States | $1.056B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Nutex Health (NUTX) | United States | $0.967B | 14.61 |
| CareDx (CDNA) | United States | $0.896B | 14.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.857B | 8.02 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.681B | 4.59 |
| InnovAge Holding (INNV) | United States | $0.570B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 44.83 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.439B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.367B | 0.00 |
| SBC Medicals (SBC) | United States | $0.361B | 0.00 |
| Oncology Institute (TOI) | United States | $0.230B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| KindlyMD (KDLY) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Biodesix (BDSX) | United States | $0.032B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |